Roman Butler Fullerton & Co. Sells 700 Shares of Omega Healthcare Investors, Inc. $OHI

Roman Butler Fullerton & Co. lowered its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 9.4% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,758 shares of the real estate investment trust’s stock after selling 700 shares during the period. Roman Butler Fullerton & Co.’s holdings in Omega Healthcare Investors were worth $264,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Cookson Peirce & Co. Inc. boosted its stake in Omega Healthcare Investors by 4.1% in the 2nd quarter. Cookson Peirce & Co. Inc. now owns 388,189 shares of the real estate investment trust’s stock worth $14,227,000 after purchasing an additional 15,377 shares during the period. Cullen Frost Bankers Inc. acquired a new position in Omega Healthcare Investors in the 2nd quarter worth $41,000. Whittier Trust Co. acquired a new position in Omega Healthcare Investors in the 2nd quarter worth $73,000. Securian Asset Management Inc. boosted its stake in Omega Healthcare Investors by 3.0% in the 2nd quarter. Securian Asset Management Inc. now owns 22,039 shares of the real estate investment trust’s stock worth $808,000 after purchasing an additional 634 shares during the period. Finally, DekaBank Deutsche Girozentrale boosted its stake in Omega Healthcare Investors by 2.3% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 58,580 shares of the real estate investment trust’s stock worth $2,172,000 after purchasing an additional 1,291 shares during the period. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Trading Up 0.2%

Omega Healthcare Investors stock opened at $40.72 on Friday. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10. The firm has a 50-day moving average of $41.60 and a 200-day moving average of $38.97. The company has a market cap of $12.01 billion, a price-to-earnings ratio of 25.13, a P/E/G ratio of 1.90 and a beta of 0.70. Omega Healthcare Investors, Inc. has a one year low of $35.04 and a one year high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.32. The company had revenue of $235.60 million for the quarter, compared to analysts’ expectations of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. Omega Healthcare Investors’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, equities analysts expect that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Mizuho upped their target price on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a research note on Thursday, September 11th. Cantor Fitzgerald assumed coverage on shares of Omega Healthcare Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $50.00 target price for the company. Weiss Ratings restated a “buy (b)” rating on shares of Omega Healthcare Investors in a research note on Wednesday, October 8th. Raymond James Financial restated an “outperform” rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Finally, Truist Financial increased their price objective on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a “hold” rating in a research note on Wednesday, September 3rd. Six research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $44.50.

Insider Activity

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the sale, the director directly owned 18,654 shares of the company’s stock, valued at approximately $749,144.64. This represents a 11.82% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.50% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.